BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15950724)

  • 1. Mapping and functional analysis of regulatory sequences in the mouse lambda5-VpreB1 domain.
    Minaee S; Farmer D; Georgiou A; Sabbattini P; Webster Z; Chow CM; Dillon N
    Mol Immunol; 2005 Jul; 42(11):1283-92. PubMed ID: 15950724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
    Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; Mårtensson IL
    Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lambda5-VpreB1 locus--a model system for studying gene regulation during early B cell development.
    Sabbattini P; Dillon N
    Semin Immunol; 2005 Apr; 17(2):121-7. PubMed ID: 15737573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
    Licence S; Persson C; Mundt C; Mårtensson IL
    Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene.
    Okabe T; Bauer SR; Kudo A
    Eur J Immunol; 1992 Jan; 22(1):31-6. PubMed ID: 1730257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
    Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
    Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene conversion events contribute to the polymorphic variation of the surrogate light chain gene lambda 5/14.1.
    Conley ME; Rapalus L; Boylin EC; Rohrer J; Minegishi Y
    Clin Immunol; 1999 Nov; 93(2):162-7. PubMed ID: 10527692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mice with single and multiple copies of transgenes reveals a novel arrangement for the lambda5-VpreB1 locus control region.
    Sabbattini P; Georgiou A; Sinclair C; Dillon N
    Mol Cell Biol; 1999 Jan; 19(1):671-9. PubMed ID: 9858590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
    Donohoe ME; Blomberg BB
    J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early B cell factor binds to a site critical for lambda5 core enhancer activity.
    Mårtensson A; Mårtensson IL
    Eur J Immunol; 1997 Jan; 27(1):315-20. PubMed ID: 9022034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer sequences located 3' of the mouse immunoglobulin lambda locus specify high-level expression of an immunoglobulin lambda gene in B cells of transgenic mice.
    Eccles S; Sarner N; Vidal M; Cox A; Grosveld F
    New Biol; 1990 Sep; 2(9):801-11. PubMed ID: 2126202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
    Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
    Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription.
    Parker MJ; Licence S; Erlandsson L; Galler GR; Chakalova L; Osborne CS; Morgan G; Fraser P; Jumaa H; Winkler TH; Skok J; Mårtensson IL
    EMBO J; 2005 Nov; 24(22):3895-905. PubMed ID: 16281060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pre-B- and B cell-specific DNA-binding protein, EBB-1, which binds to the promoter of the VpreB1 gene.
    Okabe T; Watanabe T; Kudo A
    Eur J Immunol; 1992 Jan; 22(1):37-43. PubMed ID: 1730258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
    van Loo PF; Dingjan GM; Maas A; Hendriks RW
    Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unique and immunoglobulin-like regions of surrogate light chain component lambda5 differentially interrogate immunoglobulin heavy-chain structure.
    Smith BP; Roman CA
    Mol Immunol; 2010 Mar; 47(6):1195-206. PubMed ID: 20116104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and localization of a developmental stage-specific promoter activity from the murine lambda 5 gene.
    Yang J; Glozak MA; Blomberg BB
    J Immunol; 1995 Sep; 155(5):2498-514. PubMed ID: 7650380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain.
    Minegishi Y; Hendershot LM; Conley ME
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3041-6. PubMed ID: 10077633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression.
    Wang YH; Nomura J; Faye-Petersen OM; Cooper MD
    J Immunol; 1998 Aug; 161(3):1132-9. PubMed ID: 9686571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique region of surrogate light chain component lambda5 is a heavy chain-specific regulator of precursor B cell receptor signaling.
    Guloglu FB; Bajor E; Smith BP; Roman CA
    J Immunol; 2005 Jul; 175(1):358-66. PubMed ID: 15972669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.